Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fara Brasó-Maristany"'
Autor:
Coralia Bueno-Muiño, Isabel Echavarría, Sara López-Tarruella, Marta Roche-Molina, María del Monte-Millán, Tatiana Massarrah, Yolanda Jerez, Francisco Ayala de la Peña, José Ángel García-Sáenz, Fernando Moreno, Álvaro Rodríguez-Lescure, Diego Malón-Giménez, Ana Isabel Ballesteros García, Mercedes Marín-Aguilera, Patricia Galván, Fara Brasó-Maristany, Adrienne G. Waks, Sara M. Tolaney, Elizabeth A. Mittendorf, Ana Vivancos, Patricia Villagrasa, Joel. S. Parker, Charles M. Perou, Laia Paré, Guillermo Villacampa, Aleix Prat, Miguel Martín
Publikováno v:
JAMA Oncology.
ImportanceBiomarkers to guide the use of pertuzumab in the treatment of early-stage ERBB2 (formerly HER2)-positive breast cancer beyond simple ERBB2 status are needed.ObjectiveTo determine if use of the HER2DX genomic assay (Reveal Genomics) in pretr
Autor:
Aranzazu Fernandez-Martinez, Tomás Pascual, Baljit Singh, Paolo Nuciforo, Naim U. Rashid, Karla V. Ballman, Jordan D. Campbell, Katherine A. Hoadley, Patricia A. Spears, Laia Pare, Fara Brasó-Maristany, Nuria Chic, Ian Krop, Ann Partridge, Javier Cortés, Antonio Llombart-Cussac, Aleix Prat, Charles M. Perou, Lisa A. Carey
Publikováno v:
Scientia
ImportanceBoth tumor-infiltrating lymphocytes (TILs) assessment and immune-related gene expression signatures by RNA profiling predict higher pathologic complete response (pCR) and improved event-free survival (EFS) in patients with early-stage ERBB2